Home Icon
Ha Noi CPC1 Pharmaceutical JSCLeading Pharmaceutical Technology
(+84) 98 440 46 50
English

Kalira

Ảnh sản phẩm

Active Element: Calcium polystyrene sulfonate

Dosage Form:

Composition

Calcium polystyrene sulfonate 5g

Dosage Form

Powder

Indication

Kalira is recommended for the treatment of hyperkalaemia associated with anuria or severe oliguria. It is also used to treat hyperkalaemia in patients requiring dialysis and in patients on regular haemodialysis or on prolonged peritoneal dialysis.

Dosage Adminstration

Adults, including the elderly:
- Oral:
The usual dose is 15g three or four times a day. Each dose should be given as a suspension in a small amount of water or, for greater palatability, in syrup (but not fruit juices which contain potassium), in the ratio of 3 to 4ml per gram of resin.
Use this product at least 3 hours before or 3 hours after other oral medications. For patients with gastroparesis, a 6 hour separation should be considered 
- Rectal:
This route should be reserved for the patient who is vomiting or who has upper gastrointestinal tract problems, including paralytic ileus. It may be used simultaneously with the oral route for more rapid initial results or in patients with gastroparesis, who have other orally administered medications that are administered within 6 hours of Calcium Resonium. The product may be given rectally as a suspension of 30g resin in 150ml of water or 10% dextrose, as a daily retention enema. In the initial stages administration by this route as well as orally may help to achieve a rapid lowering of the serum potassium level.
The enema should if possible be retained for a least nine hours, then the colon should be irrigated to remove the resin. If both routes are used initially it is probably unnecessary to continue rectal administration once the oral resin has reached the rectum.


Children:
- Oral
In smaller children and infants correspondingly smaller doses should be employed by using as a guide a rate of 1mEq of potassium per gram of the product as the basis for calculation. An appropriate initial dose is 1g/kg body weight daily in divided doses, in acute hyperkalaemia. Dosage may be reduced to 0.5g/kg body weight daily in divided doses for maintenance therapy.
The product is given orally, preferably with a drink (not a fruit squash because of the high potassium content) or a little jam or honey.
- Rectal
When refused by mouth it should be given rectally using a dose at least as great as that which would have been given orally, diluted in the same ratio as described for adults. Following retention of the enema, the colon should be irrigated to ensure adequate removal of the resin.
 

Neonates:
This product should not be given by the oral route. With rectal administration, the minimum effective dosage within the range 0.5g/kg to 1g/kg should be employed, diluted as for adults with adequate irrigation to ensure recovery of the resin.

Ha Noi CPC1 Pharmaceutical JSC
Contact Us
Ha Noi CPC1 Pharmaceutical JSCHa Binh Phuong Industrial Zone, Thuong Tin District, Hanoi, VietnamWhatsApp/Viber/Mobile: (+84) 98 440 46 50
FacebookLinkedinTrustPass
Copyright © CPC1HN 2024